CN102309558B - Traditional Chinese medical preparation for treating hypertension - Google Patents
Traditional Chinese medical preparation for treating hypertension Download PDFInfo
- Publication number
- CN102309558B CN102309558B CN2011102666687A CN201110266668A CN102309558B CN 102309558 B CN102309558 B CN 102309558B CN 2011102666687 A CN2011102666687 A CN 2011102666687A CN 201110266668 A CN201110266668 A CN 201110266668A CN 102309558 B CN102309558 B CN 102309558B
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- herba
- chinese medicine
- fry
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 206010020772 Hypertension Diseases 0.000 title claims abstract description 53
- 238000002360 preparation method Methods 0.000 title claims abstract description 30
- 239000003814 drug Substances 0.000 claims abstract description 81
- 229940079593 drug Drugs 0.000 claims abstract description 32
- 241001077909 Sigesbeckia Species 0.000 claims abstract description 14
- 239000000203 mixture Substances 0.000 claims abstract description 8
- 230000001631 hypertensive effect Effects 0.000 claims description 24
- 241000237636 Pheretima Species 0.000 claims description 19
- 235000003143 Panax notoginseng Nutrition 0.000 claims description 18
- 241000180649 Panax notoginseng Species 0.000 claims description 18
- 210000000582 semen Anatomy 0.000 claims description 18
- 241000237903 Hirudo Species 0.000 claims description 16
- 241000219780 Pueraria Species 0.000 claims description 13
- 239000002994 raw material Substances 0.000 claims description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 11
- 239000000843 powder Substances 0.000 claims description 8
- 239000000796 flavoring agent Substances 0.000 claims description 6
- 235000019634 flavors Nutrition 0.000 claims description 6
- 238000001035 drying Methods 0.000 claims description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 2
- 239000007888 film coating Substances 0.000 claims description 2
- 238000009501 film coating Methods 0.000 claims description 2
- 239000000706 filtrate Substances 0.000 claims description 2
- 239000008187 granular material Substances 0.000 claims description 2
- 238000005469 granulation Methods 0.000 claims description 2
- 230000003179 granulation Effects 0.000 claims description 2
- 238000002156 mixing Methods 0.000 claims description 2
- 238000010992 reflux Methods 0.000 claims description 2
- 238000003756 stirring Methods 0.000 claims description 2
- 239000006228 supernatant Substances 0.000 claims description 2
- 230000036772 blood pressure Effects 0.000 abstract description 32
- 230000000694 effects Effects 0.000 abstract description 20
- 206010067482 No adverse event Diseases 0.000 abstract description 2
- 241000143476 Bidens Species 0.000 abstract 1
- 241000201841 Celosia Species 0.000 abstract 1
- 241000545744 Hirudinea Species 0.000 abstract 1
- 241000243684 Lumbricus Species 0.000 abstract 1
- 244000131316 Panax pseudoginseng Species 0.000 abstract 1
- 235000003181 Panax pseudoginseng Nutrition 0.000 abstract 1
- 244000046146 Pueraria lobata Species 0.000 abstract 1
- 235000010575 Pueraria lobata Nutrition 0.000 abstract 1
- 240000007164 Salvia officinalis Species 0.000 abstract 1
- 235000008954 quail grass Nutrition 0.000 abstract 1
- 235000005412 red sage Nutrition 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 description 22
- 239000008280 blood Substances 0.000 description 22
- 208000024891 symptom Diseases 0.000 description 15
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 11
- 208000002173 dizziness Diseases 0.000 description 11
- 230000006870 function Effects 0.000 description 10
- 201000010099 disease Diseases 0.000 description 9
- 210000004185 liver Anatomy 0.000 description 9
- 206010019233 Headaches Diseases 0.000 description 8
- 231100000869 headache Toxicity 0.000 description 8
- 210000000952 spleen Anatomy 0.000 description 8
- 230000037396 body weight Effects 0.000 description 7
- 210000003734 kidney Anatomy 0.000 description 5
- 238000005457 optimization Methods 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 208000000059 Dyspnea Diseases 0.000 description 4
- 206010013975 Dyspnoeas Diseases 0.000 description 4
- 206010040007 Sense of oppression Diseases 0.000 description 4
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 4
- 206010047513 Vision blurred Diseases 0.000 description 4
- 230000006378 damage Effects 0.000 description 4
- 238000009826 distribution Methods 0.000 description 4
- 230000035807 sensation Effects 0.000 description 4
- 235000019615 sensations Nutrition 0.000 description 4
- 208000013220 shortness of breath Diseases 0.000 description 4
- 206010062717 Increased upper airway secretion Diseases 0.000 description 3
- 206010030113 Oedema Diseases 0.000 description 3
- 230000003276 anti-hypertensive effect Effects 0.000 description 3
- 210000004204 blood vessel Anatomy 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 230000004438 eyesight Effects 0.000 description 3
- 210000002216 heart Anatomy 0.000 description 3
- 230000001976 improved effect Effects 0.000 description 3
- 230000007774 longterm Effects 0.000 description 3
- 210000000056 organ Anatomy 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- 208000026435 phlegm Diseases 0.000 description 3
- 231100000614 poison Toxicity 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 2
- 206010010904 Convulsion Diseases 0.000 description 2
- 241000721047 Danaus plexippus Species 0.000 description 2
- 206010014080 Ecchymosis Diseases 0.000 description 2
- 102000007330 LDL Lipoproteins Human genes 0.000 description 2
- 108010007622 LDL Lipoproteins Proteins 0.000 description 2
- 241000475481 Nebula Species 0.000 description 2
- 206010033557 Palpitations Diseases 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 208000009205 Tinnitus Diseases 0.000 description 2
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 2
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 230000036461 convulsion Effects 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 210000003141 lower extremity Anatomy 0.000 description 2
- 239000002932 luster Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 230000002175 menstrual effect Effects 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 239000002574 poison Substances 0.000 description 2
- 239000000955 prescription drug Substances 0.000 description 2
- 239000010023 qingre quyu Substances 0.000 description 2
- 230000002441 reversible effect Effects 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 231100000886 tinnitus Toxicity 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 229940116269 uric acid Drugs 0.000 description 2
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 description 1
- FLNXBVJLPJNOSI-UHFFFAOYSA-N 1-[2-[(4-chlorophenyl)-phenylmethoxy]ethyl]piperidine Chemical compound C1=CC(Cl)=CC=C1C(C=1C=CC=CC=1)OCCN1CCCCC1 FLNXBVJLPJNOSI-UHFFFAOYSA-N 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 241000185686 Apocynum venetum Species 0.000 description 1
- 206010004542 Bezoar Diseases 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 206010048610 Cardiotoxicity Diseases 0.000 description 1
- 206010008111 Cerebral haemorrhage Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 241000201295 Euphrasia Species 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 206010015958 Eye pain Diseases 0.000 description 1
- 208000015220 Febrile disease Diseases 0.000 description 1
- 206010067715 Gastrointestinal sounds abnormal Diseases 0.000 description 1
- 201000005569 Gout Diseases 0.000 description 1
- 102000015779 HDL Lipoproteins Human genes 0.000 description 1
- 108010010234 HDL Lipoproteins Proteins 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 206010019468 Hemiplegia Diseases 0.000 description 1
- 206010019705 Hepatic pain Diseases 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 201000001431 Hyperuricemia Diseases 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 235000005013 Pinus cembroides Nutrition 0.000 description 1
- 235000008575 Pinus pinea Nutrition 0.000 description 1
- 240000007789 Pinus pinea Species 0.000 description 1
- 208000000418 Premature Cardiac Complexes Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 208000001647 Renal Insufficiency Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 208000037111 Retinal Hemorrhage Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 206010041349 Somnolence Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 208000005946 Xerostomia Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 239000002220 antihypertensive agent Substances 0.000 description 1
- 229940127088 antihypertensive drug Drugs 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000003143 atherosclerotic effect Effects 0.000 description 1
- 239000002876 beta blocker Substances 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000036471 bradycardia Effects 0.000 description 1
- 208000006218 bradycardia Diseases 0.000 description 1
- 231100000259 cardiotoxicity Toxicity 0.000 description 1
- 230000007681 cardiovascular toxicity Effects 0.000 description 1
- 206010008118 cerebral infarction Diseases 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 229960002544 cloperastine Drugs 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000003748 differential diagnosis Methods 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 238000004880 explosion Methods 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 230000000004 hemodynamic effect Effects 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 201000006370 kidney failure Diseases 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 230000020796 long term synaptic depression Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- IUBSYMUCCVWXPE-UHFFFAOYSA-N metoprolol Chemical compound COCCC1=CC=C(OCC(O)CNC(C)C)C=C1 IUBSYMUCCVWXPE-UHFFFAOYSA-N 0.000 description 1
- 229960002237 metoprolol Drugs 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 230000003119 painkilling effect Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 230000002028 premature Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 230000008085 renal dysfunction Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 230000002048 spasmolytic effect Effects 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- DCXXMTOCNZCJGO-UHFFFAOYSA-N tristearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- -1 vasodilatin Substances 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2011102666687A CN102309558B (en) | 2011-09-09 | 2011-09-09 | Traditional Chinese medical preparation for treating hypertension |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2011102666687A CN102309558B (en) | 2011-09-09 | 2011-09-09 | Traditional Chinese medical preparation for treating hypertension |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102309558A CN102309558A (en) | 2012-01-11 |
CN102309558B true CN102309558B (en) | 2013-02-13 |
Family
ID=45423366
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2011102666687A Active CN102309558B (en) | 2011-09-09 | 2011-09-09 | Traditional Chinese medical preparation for treating hypertension |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102309558B (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103584095B (en) * | 2013-11-04 | 2015-12-09 | 任方永 | Treat hypertensive health beverages and preparation method thereof |
CN103653237A (en) * | 2013-11-05 | 2014-03-26 | 李文彩 | Health-care cigarette capable of reducing hypertension, hyperglycemia and hyperlipidemia |
CN103830436A (en) * | 2014-03-07 | 2014-06-04 | 大连圣弘医药有限公司 | Traditional Chinese medicine composition for treating hypertension and preparation method thereof |
CN106138890A (en) * | 2016-08-18 | 2016-11-23 | 宋业琳 | A kind of Chinese medicine preparation treating hypertension and preparation method thereof |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1437959A (en) * | 2002-02-10 | 2003-08-27 | 杨志东 | Chinese prepartory for treating cardiovascular and cerebrovascular disease and preparation method |
CN101129817B (en) * | 2007-09-26 | 2010-06-30 | 王伏春 | Chinese medicine formulation for treating hypertension and method of producing the same |
-
2011
- 2011-09-09 CN CN2011102666687A patent/CN102309558B/en active Active
Also Published As
Publication number | Publication date |
---|---|
CN102309558A (en) | 2012-01-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102309558B (en) | Traditional Chinese medical preparation for treating hypertension | |
CN101979020B (en) | Chinese medicinal preparation for treating high blood pressure | |
CN103768283A (en) | Traditional Chinese medicine for treating multiple eye diseases | |
CN103749824B (en) | A kind of Herb Gynostemmae Pentaphylli blood sugar lowering blood pressure depressing health tea and preparation method thereof | |
CN103721094B (en) | Health tea for blood pressure lowering | |
CN106668607A (en) | Traditional Chinese medicine for treating gout | |
CN102600434B (en) | Compound mixture for curing cervical vertigo | |
CN104248717B (en) | A kind of foot-bath traditional Chinese medicine composition for treating hypertension and preparation method thereof | |
CN106729518A (en) | A kind of tea beverage of hypotensive and preparation method and application | |
CN102579688B (en) | Blood pressure reducing chrysanthemum and dogbane leaf traditional Chinese medicine preparation | |
CN102188659B (en) | Chinese medicine for treating cirrhosis | |
CN104606571A (en) | Fresh spinach root tea substituted drink with effects of helping produce saliva and slaking thirst and preparation method thereof | |
CN103877356B (en) | A kind of Chinese medicine preparation and preparation method for the treatment of myocardial infarction | |
CN104799276B (en) | Panax notoginseng and gastrodia elata powder for promoting normal circulation of blood and thrombolysis, and preparation method thereof | |
CN104095913B (en) | One kind plays both sides of the street pharmaceutical composition and preparation method thereof | |
CN101884735B (en) | Medicament for treating dyslipidemia and preparation method thereof | |
CN102626503B (en) | Chinese medicinal oral liquid for smoothing heart and enhancing intelligence | |
CN101357218B (en) | Externally used medicine for treating diabetes and preparation method thereof | |
CN105944042A (en) | Traditional Chinese medicine for preventing coronary heart disease | |
CN101229296A (en) | Medicine compounds for treating hypertension, heart disease and angina | |
CN104223090B (en) | The herbal cuisine preparation for the treatment of diabetes and method for making | |
CN104435762A (en) | Five-element (metal, wood, water, fire and earth) complementary powder | |
CN103961603A (en) | Traditional Chinese medicine preparationcapable of reducing blood fat and freeing vessels | |
CN104042676B (en) | It is a kind of to treat Chinese medicine composition of coronary heart disease and preparation method thereof | |
CN104491086B (en) | A kind of Chinese medicine composition for treating blood supply insufficiency of brain |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Hypertension treating traditional Chinese medicine preparation and its preparing process Effective date of registration: 20130827 Granted publication date: 20130213 Pledgee: Liuzhou Rural Credit Cooperative Association Pledgor: Guangxi Zhengtang Pharmaceutical Co., Ltd|Liu Jingming Registration number: 2013450000006 |
|
PLDC | Enforcement, change and cancellation of contracts on pledge of patent right or utility model | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20140912 Granted publication date: 20130213 Pledgee: Liuzhou Rural Credit Cooperative Association Pledgor: Guangxi Zhengtang Pharmaceutical Co., Ltd|Liu Jingming Registration number: 2013450000006 |
|
PLDC | Enforcement, change and cancellation of contracts on pledge of patent right or utility model | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Hypertension treating traditional Chinese medicine preparation and its preparing process Effective date of registration: 20140918 Granted publication date: 20130213 Pledgee: Liuzhou Rural Credit Cooperative Association Pledgor: Guangxi Zhengtang Pharmaceutical Co., Ltd|Liu Jingming Registration number: 2014450000002 |
|
PLDC | Enforcement, change and cancellation of contracts on pledge of patent right or utility model | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20160802 Granted publication date: 20130213 Pledgee: Liuzhou Rural Credit Cooperative Association Pledgor: Guangxi Zhengtang Pharmaceutical Co., Ltd|Liu Jingming Registration number: 2014450000002 |
|
PLDC | Enforcement, change and cancellation of contracts on pledge of patent right or utility model | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Hypertension treating traditional Chinese medicine preparation and its preparing process Effective date of registration: 20180724 Granted publication date: 20130213 Pledgee: Liuzhou Rural Credit Cooperative Association Pledgor: Guangxi Zhengtang Pharmaceutical Product Co., Ltd.|Liu Jingming Registration number: 2018450000019 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20200723 Granted publication date: 20130213 Pledgee: Liuzhou Rural Credit Cooperative Association Pledgor: GUANGXI ZHENGTANG PHARMACEUTICAL PRODUCT Co.,Ltd.|Liu Jingming Registration number: 2018450000019 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A traditional Chinese medicine preparation for treating hypertension Effective date of registration: 20201119 Granted publication date: 20130213 Pledgee: Liuzhou Rural Credit Cooperative Association Pledgor: GUANGXI ZHENGTANG PHARMACEUTICAL PRODUCT Co.,Ltd.|Liu Jingming Registration number: Y2020450000045 |